VAERS reports by lot

Merck Pneumococcal lot R009163: VAERS reports

35 VAERS reports list lot R009163 as a Merck Pneumococcal vaccine, received between 2018-06-06 and 2020-02-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
6%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5537%
General / Systemic (non-local)2718%
Allergic / Anaphylactic2114%
Dermatological (non-injection-site)1510%
Musculoskeletal128%
Cardiac / Cardiovascular75%
Respiratory32%
Gastrointestinal32%
Neurological21%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida4
Georgia4
South Carolina3
Minnesota2
Virginia2
Massachusetts2
New Mexico2
Louisiana1
New York1
New Jersey1
Missouri1
Michigan1

Reports by month received

2018-063
2018-076
2018-084
2018-095
2018-108
2018-111
2019-011
2019-022
2019-061
2019-092
2020-011
2020-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.